Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments

SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Jafari, Anya, Dadkhahfar, Sahar, Perseh, Sahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217119/
https://www.ncbi.nlm.nih.gov/pubmed/32460133
http://dx.doi.org/10.1016/j.critrevonc.2020.102982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217119/
https://www.ncbi.nlm.nih.gov/pubmed/32460133
http://dx.doi.org/10.1016/j.critrevonc.2020.102982

Ejemplares similares